A successful partnership between Pitt’s BioForge subsidiary and a New York-based biotech startup has kept the latter in ...
Raphas, a mass-production platform company specializing in microneedle technology, has teamed up with Japanese electronics ...
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe ...
TROP2抗体药物偶联物(antibody-drug conjugates, ADCs)已显示出有前景的抗肿瘤活性,但此类药物在肺大细胞神经内分泌癌(large cell neuroendocrine carcinoma, LCNEC)中的活性以及TROP2表 TROP2抗体药物偶联物(antibody-drug conjugates, ADCs)已显示出有前景的抗肿瘤活性,但此类药物在肺大细胞神 ...